Cell surface modification in the treatment of experimental cancer: Neuraminidase or concanavalin a
- 1 October 1974
- Vol. 34 (S8) , 1541-1547
- https://doi.org/10.1002/1097-0142(197410)34:8+<1541::aid-cncr2820340828>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- THE COMPLEMENT-BINDING AND ABSORPTIVE CAPACITY OF HUMAN WHITE BLOOD CELLS TREATED WITH NEURAMINIDASE1Transplantation, 1972
- Immunospecific Regression of Methylcholanthrene Fibrosarcoma Using NeuraminidaseAnnals of Surgery, 1972
- SIALIC ACIDS ON THE PLASMA MEMBRANE OF CULTURED HUMAN LYMPHOID CELLSThe Journal of cell biology, 1972
- MODIFICATION OF GRAFT-VERSUS-HOST DISEASE BY NEURAMINIDASE TREATMENT OF DONOR CELLS DECREASED TOLEROGENICITY OF NEURAMINIDASE-TREATED CELLSTransplantation, 1971
- Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCGScience, 1971
- Further Studies on the Effect of Neuraminidase on Tumor Cell TransplantabilityTissue Antigens, 1971
- Some physical and chemical properties of a phytohemagglutinin isolated from Phaseolus vulgarisBiochimica et Biophysica Acta (BBA) - Protein Structure, 1967
- Interaction of concanavalin A, a phytohemagglutinin, with model substratesBiochimica et Biophysica Acta (BBA) - General Subjects, 1966
- Cellular localization of the mitogenic principle of phytohaemagglutinin in leucocyte culturesExperimental Cell Research, 1964
- The Reaction of Concanavalin-A with Mucopolysaccharides1Journal of the American Chemical Society, 1956